Şunu aradınız:: insulinresistensen (Danca - İngilizce)

pioglitazons virkninger kan medieres af en reduktion af insulinresistensen.
pioglitazone effects may be mediated by a reduction of insulin resistance.

stoffet reducerer glykæmi ved at nedsætte insulinresistensen i fedtvæv, skeletmuskulatur og lever.
it reduces glycaemia by reducing insulin resistance at adipose tissue, skeletal muscle and liver.

Årsagssammenhængen er ikke entydig, men for store mængder fedtvæv synes at øge insulinresistensen og dermed også sukkerniveauet.
the causal mechanisms behind this relationship are not clear, but excessive adipose tissue seems to increase insulin resistance and, therefore, glucose levels.

dette skyldtes, at pioglitazon mindskede den maternale hyperinsulinæmi og øgede insulinresistensen, som optræder under graviditet og derved reducerer tilgængeligheden af metaboliske substrater til fostervækst.
this was attributable to the action of pioglitazone in diminishing the maternal hyperinsulinaemia and increased insulin resistance that occurs during pregnancy thereby reducing the availability of metabolic substrates for foetal growth.